oxonic acid has been researched along with Cancer of Oropharnyx in 8 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our analysis suggests that cancer of the oropharynx and CRT are important risk factors for severe OM in HNC patients that undergo RT or CRT involving S-1." | 1.46 | Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1. ( Fujii, N; Hashimoto, T; Kogo, M; Nagatani, A; Naito, Y; Ogawa, Y; Okabe, T; Sasaki, T; Sunaga, T; Tomura, K, 2017) |
| "Various treatments for oropharynx cancer included radiotherapy, arterial injection chemotherapy (as well as combined chemoradiotherapy), combined concurrent chemoradiotherapy, and surgical resection and reconstruction." | 1.36 | [Effectiveness of simultaneous combination therapy using S-1, nedaplatin and radiotherapy for 7 cases of oropharynx cancer]. ( Egawa, S; Furuya, A; Kaburagi, A; Kamakazu, K; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H, 2010) |
| " The plasma 5-FU level was measured, and adverse events appearing after administration were monitored." | 1.33 | [Pharmacokinetics and adverse event of TS-1 administered through gastrostomy]. ( Hasegawa, M; Hirano, K; Nakamura, K, 2005) |
| "We report a recent case of squamous cell carcinoma originating in the right tonsil, with metastasis to the right superior cervical lymph nodes (T3N2bM0: stage IVA)." | 1.32 | [A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1]. ( Hashimoto, K; Iguchi, H; Nakamura, A; Sunami, K; Takayama, M; Yamane, H, 2003) |
| "A 60-year-old man had a recurrence of squamous cell carcinoma at the right side of the tongue base." | 1.31 | [Long-term complete response to treatment with TS-1 in a patient with oropharyngeal squamous cell carcinoma]. ( Fukuda, S; Furuta, Y; Homma, A; Inuyama, Y; Oridate, N; Suzuki, F, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakisaka, N | 1 |
| Yoshida, S | 1 |
| Kondo, S | 1 |
| Kita, M | 1 |
| Endo, K | 1 |
| Tsuji, A | 1 |
| Murono, S | 1 |
| Muramatsu, M | 1 |
| Yoshizaki, T | 1 |
| Nagatani, A | 1 |
| Ogawa, Y | 1 |
| Sunaga, T | 1 |
| Tomura, K | 1 |
| Naito, Y | 1 |
| Fujii, N | 1 |
| Okabe, T | 1 |
| Hashimoto, T | 1 |
| Kogo, M | 1 |
| Sasaki, T | 1 |
| Shimane, T | 2 |
| Mori, T | 1 |
| Ono, T | 1 |
| Kaburagi, A | 1 |
| Egawa, S | 2 |
| Furuya, A | 1 |
| Kamakazu, K | 1 |
| Kobayashi, S | 2 |
| Sanbe, T | 2 |
| Suzaki, H | 2 |
| Ohnishi, K | 1 |
| Shioyama, Y | 1 |
| Nakamura, K | 2 |
| Nakashima, T | 1 |
| Ohga, S | 1 |
| Nonoshita, T | 1 |
| Yoshitake, T | 1 |
| Terashima, K | 1 |
| Komune, S | 1 |
| Honda, H | 1 |
| Ikeda, K | 1 |
| Akiyama, R | 1 |
| Uzuki, A | 1 |
| Sugimoto, A | 1 |
| Ikenoya, Y | 1 |
| Hayashi, T | 1 |
| Homma, A | 1 |
| Suzuki, F | 1 |
| Oridate, N | 1 |
| Furuta, Y | 1 |
| Inuyama, Y | 1 |
| Fukuda, S | 1 |
| Iguchi, H | 1 |
| Hashimoto, K | 1 |
| Sunami, K | 1 |
| Takayama, M | 1 |
| Nakamura, A | 1 |
| Yamane, H | 1 |
| Hirano, K | 1 |
| Hasegawa, M | 1 |
2 trials available for oxonic acid and Cancer of Oropharnyx
| Article | Year |
|---|---|
HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinatio | 2015 |
Concurrent chemoradiotherapy with S-1 as first-line treatment for patients with oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Humans; Male; Middle Aged; Oropharyngeal | 2011 |
6 other studies available for oxonic acid and Cancer of Oropharnyx
| Article | Year |
|---|---|
Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Combinations; Female; | 2017 |
[Effectiveness of simultaneous combination therapy using S-1, nedaplatin and radiotherapy for 7 cases of oropharynx cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; | 2010 |
[Efficacy of concurrent chemoradiotherapy in cases with cervical lymph node metastasis from oropharyngeal or hypopharyngeal cancer].
Topics: Adult; Aged; Aminohydrolases; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Ther | 2011 |
[Long-term complete response to treatment with TS-1 in a patient with oropharyngeal squamous cell carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combin | 2002 |
[A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality | 2003 |
[Pharmacokinetics and adverse event of TS-1 administered through gastrostomy].
Topics: Deglutition Disorders; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gas Chromatogr | 2005 |